cases and a considerable reduction of the prolactinaemia in one. The reduction in the tumour volume was superior or equal to 50% in eight cases out of 13 (illustrated in Fig 1) . The visual tolerance was good. In all the cases the ocular pressure was -20 mm Hg. During the first year oftreatment, modifications ofthe ocular pressure were observed: five with a mean reduction of 4 mm Hg, three with a mean increase of 3 mm Hg. These modifications were transient. There was no difference between the ocular pressure measured before the treatment and at the last control. The aspect of the optic disc remained unchanged during the treatment; 10 were normal, three were pale. The visual results including visual acuity and visual field before inclusion were normal in six cases and abnormal in seven cases.
BASELINE NORMAL VISUAL FUNCTION ( (Fig 2) . In the two other cases VF improved in 4 months and 1 month respectively.
We shall examine case No 10 in more detail.
After 16 months of closely monitored treatment, the reduction of the volume of the tumour on CT scan was incomplete in spite of a good control of prolactinaemia and an improved VF. The patient suddenly complained of headache and his vision decreased bilaterally from normal to RE: 6/9, LE: 6/18 to (lower part of Fig 3) and to 'no light perception' in either eye associated with a right ptosis within 2 days. On the CT scan a heterogeneous aspect of the macroadenoma associated with an increase ofsize was compatible with the diagnosis of pituitary necrosis (Fig 4) .
Surgical treatment with a trans-sphenoidal approach was quickly carried out. The visual acuity of the patient rapidly improved and reach 6/9 and 6/12 1 month after surgery. In spite of a good anatomical result the PRL level rose 
